6 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 4 Not applicable, 1 Early Phase 1, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Terminated 2 |
| Early Phase 1 | 1 | Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Skin Melanoma: new trials by email Literature Review of Skin Melanoma trials Research Report on Skin Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria Skin Melanoma, Cutaneous Melanoma | Recruiting | University of Modena and Reggio Emilia | 300 | 2025-07-07 | 2025-12-18 | |
| Effects of Ultraviolet B Exposure Using a Ultraviolet Skin Care Device on Vitamin D Production and Immune Response in Healthy Adults Ultraviolet B exposure to produce vitamin D synthesis - Skin Inflammation, Skin Melanoma | Not applicable | Completed | Wonju Severance Christian Hospital | 27 | 2024-03-20 | 2025-04-15 |
| Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma RPH-075, Keytruda® - Skin Melanoma | Phase 3 | Completed | R-Pharm | 266 | 2023-09-27 | 2026-07-15 |
| Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms RPH-075, Keytruda® - Skin Melanoma, Squamous Non-small-cell Lung Cancer | Phase 1 | Completed | R-Pharm | 90 | 2023-03-01 | 2026-07-15 |
| Defining the Role of the Skin Microbiome in Immune-related Adverse Events skin swabs at lesional and non-lesional sites, skin swabs on skin - Vitiligo, Skin Melanoma | Not applicable | Terminated | University Hospital, Bordeaux | 57 | 2022-01-11 | 2026-06-23 |
| Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry Oxygen - Skin Lesion, Skin Cancer | Not applicable | Terminated | West Virginia University | 3 | 2019-10-17 | 2026-02-27 |
| Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma Encorafenib, Binimetinib, Nivolumab - Melanoma (Skin), Skin Cancer | Early Phase 1 | Active not recruiting | H. Lee Moffitt Cancer Center and Research Institute | 14 | 2018-06-14 | 2026-02-05 |
| Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans Written Educational Brochure, Online educational video - Skin Carcinoma, Skin Melanoma | Not applicable | Completed | Case Comprehensive Cancer Center | 143 | 2015-04-01 | 2015-12-03 |
| Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin Surgical resection, Adjuvant Radiotherapy, interferon alfa - Melanoma Stage I, Melanoma Stage III | Phase 2 | Completed | MIPO Clinic | 278 | 2014-01-01 | 2026-06-30 |
| Differential Risks for Melanoma: p16 and DNA Repair self-administered questionnaire and blood draw, health questionnaire, blood draw and skin exam - Melanoma, Skin Melanoma | Completed | Memorial Sloan Kettering Cancer Center | 323 | 1997-02-01 | 2011-04-20 |
Melanoma (10) · Skin Neoplasms (3) · Neoplasms (2) · Carcinoma (1) · Dermatitis (1) · Lung Neoplasms (1) · Occupational Diseases (1) · Squamous Cell Carcinoma of Head and Neck (1) · Vitiligo (1)
Neoplasms by Histologic Type (10) · Neoplasms by Site (10) · Neoplasms, Germ Cell and Embryonal (10) · Neoplasms, Nerve Tissue (10) · Neuroectodermal Tumors (10) · Neuroendocrine Tumors (10) · Nevi and Melanomas (10) · Skin Diseases (10) · Skin and Connective Tissue Diseases (10) · Neoplasms (8) · Skin Neoplasms (7) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Hypopigmentation (1) · Lung Diseases (1)
pembrolizumab (2) · Blood Specimen Collection (1) · CD4-CD8 Ratio (1) · Cisplatin (1) · Dacarbazine (1) · Educational Status (1) · Flow Cytometry (1) · Interferon-alpha (1) · Methods (1) · Monitoring, Immunologic (1) · Nivolumab (1) · Oxygen (1) · Radiotherapy, Adjuvant (1) · binimetinib (1) · encorafenib (1)
R-Pharm (2) · Case Comprehensive Cancer Center (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · MIPO Clinic (1) · Memorial Sloan Kettering Cancer Center (1) · University Hospital, Bordeaux (1) · University of Modena and Reggio Emilia (1) · West Virginia University (1) · Wonju Severance Christian Hospital (1)
United States (4) · Russia (2) · France (1) · Italy (1) · South Korea (1)
Mikhail Samsonov (2) · Alberto Modenese, MD. PhD (1) · Francesca Farnetani, MD (1) · Irlene Orlow, PH.D., M.S. (1) · Jeremy Bordeaux (1) · Paola Ferri, MSc (1) · Sergio Rovesti, MD (1) · Todd Tenenholz, MD (1) · Zeynep Eroglu, M.D. (1)
PMID 26995019, PMID 28478931, PMID 28587288, PMID 30792021, PMID 32057276, PMID 32352425, PMID 40056460
P30CA043703 (1)